United States - English - NLM (National Library of Medicine)

upsher-smith laboratories, llc - testosterone (unii: 3xmk78s47o) (testosterone - unii:3xmk78s47o) - testosterone 50 mg in 5 g - vogelxo is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: - primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. these men usually have low serum testosterone levels and gonadotropins (follicle-stimulating hormone [fsh], luteinizing hormone [lh]) above the normal range. - hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. these men have low testosterone serum levels but have gonadotropins in the normal or low range. limitations of use: - safety and efficacy of vogelxo in men with "age-related hypogonadism" (also referred to as "late-onset hypogonadism") have not been established. - safety and effic

United States - English - NLM (National Library of Medicine)

aleor dermaceuticals limited - testosterone (unii: 3xmk78s47o) (testosterone - unii:3xmk78s47o) - testosterone gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: - primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. these men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [fsh], luteinizing hormone [lh]) above the normal range. - hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. these men have low testosterone serum concentrations, but have gonadotropins in the normal or low range. limitations of use: - safety and efficacy of testosterone gel, 1.62% in men with "age-related hypogonadism" (also referred to as "lat

Canada - English - Health Canada

taro pharmaceuticals inc - testosterone - gel - 1% - testosterone 1% - androgens

Canada - English - Health Canada

taro pharmaceuticals inc - testosterone - gel - 1% - testosterone 1% - androgens

Canada - English - Health Canada

taro pharmaceuticals inc - testosterone cypionate - solution - 100mg - testosterone cypionate 100mg - androgens

United States - English - NLM (National Library of Medicine)

a-s medication solutions - testosterone cypionate (unii: m0xw1ubi14) (testosterone - unii:3xmk78s47o) - testosterone cypionate 200 mg in 1 ml - testosterone cypionate injection, usp is indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone. - primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome; or orchidectomy. - hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (lhrh) deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation. safety and efficacy of testosterone cypionate in men with “age-related hypogonadism” (also referred to as “late-onset hypogonadism”) have not been established. - known hypersensitivity to the drug - males with carcinoma of the breast - males with known or suspected carcinoma of the prostate gland - women who are pregnant (see precautions, pregnancy ) - patients with serious cardiac, hepatic or renal disease (see warnings ) testosterone cypionate injection contains testoster

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmaceutical company jelfa s.a. - testosterone (testosterone propionate), testosterone (testosterone phenylpropionate), testosterone (testosterone isocaproate), testosterone (testosterone decanoate) - solution for i/m injection, oily - 30mg/ml+ 60mg/ml+ 60mg/ml+ 100mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmaceutical company jelfa s.a. - testosterone (testosterone propionate), testosterone (testosterone phenylpropionate), testosterone (testosterone isocaproate), testosterone (testosterone decanoate) - oily solution for i/m injection - 30mg/ml+ 60mg/ml+ 60mg/ml+ 100mg/ml

Canada - English - Health Canada

taro pharmaceuticals inc - testosterone undecanoate - capsule - 40mg - testosterone undecanoate 40mg - androgens

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - testosterone propionate, quantity: 30 mg/ml; testosterone phenylpropionate, quantity: 60 mg/ml; testosterone isocaproate, quantity: 60 mg/ml; testosterone decanoate, quantity: 100 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; arachis oil - indicatiosns as at 4 december 1996: androgen replacement therapy for confirmed testosterone deficiency in males.